At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 13 enrolled
Drug / intervention
oxybutynin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Determination of Serum Oxybutynin Levels After Using Oxybutynin Transdermal Delivery System and Transdermal Gel With and Without Standardized Heat Application in Healthy Human Volunteers
In Brief
A Early Phase 1 clinical trial evaluating oxybutynin for Heat Effect. Completed, enrolled 13 participants across 1 site.
Detailed Summary
This research study is intended to determine the effect of heat and occlusion on oxybutynin products.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeat Effect
CountriesUnited States
CollaboratorsFood and Drug Administration (FDA)
Timeline
Early Ph 1CompletedFinished
201820192020202120222023202420252026
First PostedJul 2017
Enrollment StartJan 2018
Primary CompletionNov 2019
TodayJul 2026
First PostedJul 2, 2017
Enrollment StartJan 2, 2018
Primary CompletionNov 13, 2019
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 9 years ago
Interventions
oxybutynindrug
patch
oxybutynindrug
gel